Cellectar receives delinquency notification letter from Nasdaq, co to restate financial statements

seekingalpha08-24

Cellectar Biosciences (NASDAQ:CLRB) on Friday said it has received a delinquency notification letter from Nasdaq. The notice indicated that the company is not in compliance with the periodic financial...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2461529967?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-24 05:27","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2461529967","market":"nz","top_or_hot":-1,"title":"Cellectar receives delinquency notification letter from Nasdaq, co to restate financial statements","media":"seekingalpha","content":"<div>\n<p>Cellectar Biosciences (NASDAQ:CLRB) on Friday said it has received a delinquency notification letter from Nasdaq. The notice indicated that the company is not in compliance with the periodic financial...</p>\n\n<a href=\"https://seekingalpha.com/news/4143512-cellectar-receives-delinquency-notification-letter-from-nasdaq-co-to-restate-financial-statements\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cellectar receives delinquency notification letter from Nasdaq, co to restate financial statements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellectar receives delinquency notification letter from Nasdaq, co to restate financial statements\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-24 05:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4143512-cellectar-receives-delinquency-notification-letter-from-nasdaq-co-to-restate-financial-statements><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cellectar Biosciences (NASDAQ:CLRB) on Friday said it has received a delinquency notification letter from Nasdaq. The notice indicated that the company is not in compliance with the periodic financial...</p>\n\n<a href=\"https://seekingalpha.com/news/4143512-cellectar-receives-delinquency-notification-letter-from-nasdaq-co-to-restate-financial-statements\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://seekingalpha.com/news/4143512-cellectar-receives-delinquency-notification-letter-from-nasdaq-co-to-restate-financial-statements","article_id":"2461529967","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2461529967","pubTimestamp":1724448470,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Cellectar Biosciences  on Friday said it has received a delinquency notification letter from Nasdaq. The notice indicated that the company is not in compliance with the periodic financial report filing requirement set forth in Nasdaq listing rules as a result of the company's delay in filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024.  The delay in filing the Second Quarter 10-Q is a result of the company’s need to restate certain previously filed financial statements. The financial statement changes are all expected to be non-cash and non-operating. CLRB +1.36% after hours to $2.149. Source: Press Release","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","QLD":"纳指两倍做多ETF","BK4139":"生物科技","TQQQ":"纳指三倍做多ETF","PSQ":"纳指反向ETF","CLRB":"Cellectar Biosciences Inc.","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","BK4588":"碎股","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","QQQ":"纳指100ETF","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD",".IXIC":"NASDAQ Composite","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","QID":"纳指两倍做空ETF","NDAQ":"纳斯达克OMX交易所","BK4112":"金融交易所和数据","SQQQ":"纳指三倍做空ETF"},"translate_title":"Cellectar收到科罗拉多州纳斯达克的拖欠通知函，以重述财务报表","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLRB":1,"NQmain":1,".IXIC":1,"NDAQ":1,"TQQQ":0.6,"SQQQ":0.6,"QQQ":0.6,"QLD":0.6,"QID":0.6,"PSQ":0.6,"MNQmain":0.6},"content_text":"Cellectar Biosciences (NASDAQ:CLRB) on Friday said it has received a delinquency notification letter from Nasdaq. The notice indicated that the company is not in compliance with the periodic financial report filing requirement set forth in Nasdaq listing rules as a result of the company's delay in filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024.  The delay in filing the Second Quarter 10-Q is a result of the company’s need to restate certain previously filed financial statements. The financial statement changes are all expected to be non-cash and non-operating. CLRB +1.36% after hours to $2.149. Source: Press Release","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2461529967"}